Catalyst Event
Pfizer Inc (PFE) · Other
From Akros U.S. High Dividend Index (AUHD20)
3/19/2026, 12:00:00 AM
On March 19, 2026, Pfizer announced that its combination therapy of TALZENNA plus XTANDI significantly improved radiographic progression-free survival in patients with a specific type of metastatic prostate cancer.
Korean Translation
2026년 3월 19일, 화이자는 탈제나(TALZENNA)와 엑스탄디(XTANDI) 병용 요법이 특정 유형의 전이성 전립선암 환자의 방사선학적 무진행 생존기간을 유의미하게 개선했다고 발표함.
Related Recent Events
Pfizer Inc (PFE) · Earnings Release
Pfizer's Q1 2026 earnings release is scheduled for May 5, 2026, scheduled.
5/5/2026, 12:00:00 AM
Antero Midstream Corp (AM) · Earnings Release
Q1 2026 earnings release, with low importance estimated due to minimal impact of date announcements, scheduled.
4/29/2026, 12:00:00 AM
Peoples Bancorp Inc (PEBO) · Earnings Release
First quarter 2026 earnings release is scheduled.
4/28/2026, 12:00:00 AM
Verizon Communications Inc (VZ) · Earnings Release
Verizon is scheduled to release its Q1 2026 earnings results on April 27, 2026, with analysts forecasting earnings of approximately $1.23 per share; low importance is estimated as market impact is typically deferred until the release scheduled.
4/27/2026, 12:00:00 AM
First Financial Bancorp. (FFBC) · Earnings Release
Benzinga and MarketBeat estimate First Financial Bancorp. will report Q1 2026 earnings on 2026-04-23, with BankFinancial integration trends likely a key focus; a mid-single-digit stock move is estimated.
4/23/2026, 12:00:00 AM
CVB Financial Corp (CVBF) · Earnings Release
First quarter 2026 earnings conference call for 2026-04-23 scheduled.
4/23/2026, 12:00:00 AM